StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by KPOIndustrieson Apr 14, 2020 9:58am

72 Views

Post# 30906891

RE:Be aware - The Basher's Handbook

For fu$k sakes... enough!!!! This is why I'm pi$$ed off. This nonsense here, "bashers don't bash a bad stock". I'm not a fuc$ing basher. I'm a pi$$ed off investor, like all of you!!! We are all askingthe same question.. where and when will the news come out...we all wait patiently week after week. It's been two weeks and no update. Other companies have a product gone from testing and are distributing. StageZero can't tell us anything. But hey, I'm a basher. I'm a realist, I realize this is likely all BS. Read the news release. They are considering talking... hmmmmm